stars 1 stars 2 stars 3

A pioneer in immuno-modulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers.

Website http://www.napajen.com
Revenue $7 million
Employees 2 (1 on RocketReach)
Founded 2022
Address 533 Airport Blvd Ste 527, Burlingame, California 94010, US
Phone +1 816-506-8524
Fax (650) 401-2221
Technologies
Industry Biotechnology, Biotechnology Research, Drug Stores & Pharmacies, Artificial Intelligence, Drug Discovery, Retail, Data and Analytics, Science and Engineering, Software, Medical, Health Care, Pharmaceutical
Web Rank 21 Million
Keywords Immunology, Immunomodulation, Nucleic Acid Therapeutics, Targeted Therapy, Gene Therapy, Clinical Trials, Drug Development, Biotechnology, Hematopoietic Stem Cell Transplantation, Precision Medicine, Pharmaceutical Research, Oncology
Competitors Siemens, Roche, Thermo Fisher Scientific, Abbott, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +53 more (view full list)
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies

Immunohelix Questions

The Immunohelix annual revenue was $7 million in 2026.

Tadahiro Matsudaira is the VP of Development of Immunohelix.

1 people are employed at Immunohelix.

Immunohelix is based in Burlingame, California.

The NAICS codes for Immunohelix are [32541, 325, 3254, 32].

The SIC codes for Immunohelix are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users